Methylation marks the path for biomarker development in breast cancer research

Cancer Biology and Therapy

Volumn 8, Issue 23, 2009, Pages 2258-2260

  Corn, Paul G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Biomarker; CpG island; Inflammatory breast cancer; Methylation

Indexed keywords

BREAST CANCER; CANCER RESEARCH; CLINICAL FEATURE; DISEASE MARKER; DNA METHYLATION; HEALTH PRACTITIONER; HISTOPATHOLOGY; HUMAN; NOTE; PROTEIN EXPRESSION;

EID: 73949105209     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.23.10415     Document Type: Note

References (14)

1. Manne U, Srivastava RG, Srivastava S. Recent advances in biomarkers for cancer diagnosis and treatment. Drug Discov Today 2005; 10:965-76.
2. Sawyers CL. The cancer biomarker problem. Nature 2008; 452:548-52.
3. Liszewski K. Optimizing Utilization of Biomarkers. Genetic Engineering and Biotechnology News 2009; 28.
4. Lopez J, Percharde M, Coley HM, Webb A, Crook T. The context and potential of epigenetics in oncology. Br J Cancer 2009; 100:571-7.
5. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349:2042-54.
6. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006; 6:107-16.
7. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61:3225-9.
8. Dulaimi E, Hillinck J, Ibanez dC I, Al-Saleem T, Cairns P. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res 2004; 10:6189-93.
9. Krassenstein R, Sauter E, Dulaimi E, Battagli C, Ehya H, Klein-Szanto A, et al. Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Clin Cancer Res 2004; 10:28-32.
10. Fackler MJ, Rivers A, Teo WW, Mangat A, Taylor E, Zhang Z, et al. Hypermethylated genes as biomarkers of cancer in women with pathologic nipple discharge. Clin Cancer Res 2009; 15:3802-11.
11. Van dA I, Bovie C, Svensson C, Limame R, Trinh XB, van DP, et al. Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes. Cancer Biol Ther 2009; 8.
12. Resetkova E. Pathologic aspects of inflammatory breast carcinoma: part 1. Histomorphology and differential diagnosis. Semin Oncol 2008; 35:25-32.
13. Bertucci F, Finetti P, Rougemont J, Charafe-Jauffret E, Nasser V, Loriod B, et al. Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy. Cancer Res 2004; 64:8558-65.
14. Bertucci F, Finetti P, Rougemont J, Charafe-Jauffret E, Cervera N, Tarpin C, et al. Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. Cancer Res 2005; 65:2170-8.